St. Bernards Medical Center is a 438-bed acute-care hospital in Jonesboro, Arkansas. The hospital, established on July 5, 1900, is the flagship facility of its nonprofit parent, St. Bernards Healthcare, serving as a regional referral center for 23 counties in northeast Arkansas and southeast Missouri.

There are 438 beds in St. Bernard's Medical Center.

During the past decade, St. Bernard's Medical Center conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 13 clinical trials were completed, i.e. on average, 44.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 4 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Bernard's Medical Center" #1 sponsor was "Boston Scientific Corporation" with 7 trials, followed by "Abbott Medical Devices" with 4 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Bernard's Medical Center" #1 collaborator was "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "St. Bernard's Medical Center" are "Coronary Artery Disease" (3 trials), "Peripheral Arterial Disease" (3 trials), "Atrial Fibrillation" (2 trials), "Breast Cancer" (2 trials) and "Chemotherapy-induced Thrombocytopenia" (2 trials). Many other conditions were trialed in "St. Bernard's Medical Center" in a lesser frequency.

Most popular intervention types in "St. Bernard's Medical Center" are "Drug" (20 trials), "Device" (17 trials), "Biological" (6 trials), "Other" (5 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Docetaxel" (4 trials), "Abemaciclib" (3 trials), "Anastrozole" (2 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Bernard's Medical Center" are 32 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "St. Bernard's Medical Center". undefined are not yet recruiting, 10 are recruiting, 15 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in St. Bernard's Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in St. Bernard's Medical Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".

St. Bernard's Medical Center has several departments that took part in Clinical trials: "Ben E. Owens Cancer Treatment Center at St. Bernard's Medical Center" - 2 trials